chrisvoncsefalvay/vaers-outcomes huggingface dataset:
For the first time ever, I had what I determined (based on internet searching) to be an ocular migraine.  My vision was distorted in both eyes, although the distortion was stronger when looking to the left.  There was a circular area that was fuzzy and a bit wavy like looking through water.  The circular distortion area seemed to be outlined by a ring of brighter light. No flashes or floaters.  I did not have a migraine headache then or afterwards; I've never had a migraine headache.  I followed the on-line advise and laid down and did try to use my eyes for about an hours.  The distortion faded within an hour or two; it has not recurred.  I did not connect it to the vaccine as a potential source at that time.
Started from 1/30 Saturday, my left hand fingers started getting numb, 1/31 Sunday the numbness expended to half of the left hand palm, 2/1 Monday the numbness spreads to lower arm.
pt received the second dose of pfizer vaccine today on 4/9/2021 at around 2:30 pm. she came back around 4:30pm in the parking lot. She said she started having an asthma attack when driving. she used her albuterol inhaler twice but that wasn't working. We called 911 for her. Ambulance came and took her to hospital. I called the patient at 8pm. she said was she was being discharged and is feeling fine now.
Headaches over the weekend; Seizure; Left arm was sore for about 4 days; This spontaneous case was reported by a consumer and describes the occurrence of SEIZURE in a 48-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 088021A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history was provided by the reporter.  Concomitant products included LEVETIRACETAM and DIVALPROEX for an unknown indication.    On 18-Aug-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 18-Aug-2021, the patient experienced PAIN IN EXTREMITY. On 19-Aug-2021, the patient experienced SEIZURE (seriousness criterion medically significant). On 21-Aug-2021, the patient experienced HEADACHE. On 19-Aug-2021, SEIZURE had resolved. On 22-Aug-2021, PAIN IN EXTREMITY and HEADACHE had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment information was not provided.Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded. Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
Adverse event: Diagnosed herpangina starting 8/7/2022. Symptoms: Fever, interrupted sleep for 7 days, decreased appetite for 7 days, over 15 sores in mouth, 3 sores on face, inflamed gums, bleeding from mouth due to inflamed gums/ sores. Irritability for 7-8 days. Sores in mouth/ face and inflamed lasting over 7 days.   Treatment: Tylenol and ibuprofen
Pt received Flu vaccine 11/4/10 at mass Flu clinic c/o pain started the next day hurt for 2 days, got better but has not stopped says couldn't move arm those 2 days & now has limited mobility - (Rt) arm site of inj. clear, no redness, no edema, cool to touch tenderness noted when touch area toward underarm.
vaccine was administered subcutaneously instead of intramuscular according to her; This is a spontaneous report from a contactable registered nurse (patient) via Pfizer-sponsored program via medical information team. A 31-year-old female patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, lot number ER8730, Expiration date 31Jul2021), subcutaneously administered in the Left Upper Arm on 19Apr2021 (age at the time of vaccination 31-year-old) at a single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. Historical vaccine includes first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, lot number EN6200, Expiration date 30Jun2021), via unknown route administered in the Left Upper Arm on 29Mar2021 at a single dose for COVID-19 immunization. Patient got the 2nd shot of the vaccine on 19Apr2021 and, she felt that the vaccine was not administered properly as she was bigger than the usual, vaccine was administered subcutaneously instead of intramuscular according to her. She stated that she is a big girl and does not think the needle reached her muscle. Reporter would like to know the efficacy of the covid vaccine if administered subcutaneously as opposed to intramuscularly. Do I still have the same percentage of coverage if I received the covid vaccine subcutaneously, instead of muscularly? No PQC present. Upon follow up on 19Apr2021 as per the reporter the report was serious with seriousness criteria-Other medically important condition. Report is not related to a study or program. The outcome of the events was unknown.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.  Follow-up (19Apr2021): New information received from a contactable consumer. This consumer (patient) reported in response to consumer letter sent via follow-up letter which included: reporter seriousness added, dose details lot number and expiration date added for both the doses.  Amendment: This follow-up report is also being submitted to amend previously reported Information: delete the off-label use event as this is a medication error based on the description of the event and was not off label use.; Sender's Comments: Based on the information available and a close temporal association, a possible contributory role of the suspect BNT162B2 cannot be excluded for the reported events of Inappropriate route of vaccination,Off label use. The case will be reassessed once new information is available.
Client complained of Numbness on the right side of her face/tongue approximately 15-18 minutes after injection. Client described it as "like going to the dentist". Blood pressure 170/100 during episode. O2 sat 100%, HR 69. She denied shortness of breath and had ho stridor or compromised breathing. Client sat with observer for another 15-20 minutes, and stated that the symptoms were going away. She stated that her mother is a nurse and she would have her mom bring her to the ER if symptoms worsened.
Excessive pain in location where needle administered & inability to move arm which continued until May 2011.  As of July 2011 pain finally subsided but not entirely gone (depends on how I move my arm).
Not sure exactly when this problem began, but definitely after vaccination. Both hands feel very arthritic. Most proximal knuckle of left long finger is visibly enlarged and painful to any pressure. That finger is very uncomfortable almost all the time. Neither heat nor Ibuprofen decrease pain. No specific finger on the right hand is more affected, but that hand is frequently painful and stiff. Again, neither heat nor Ibuprofen have any effect on the pain. I had not noticed these symptoms prior to Covid-19 vaccination.
Itching, injection site pain 14 hrs. after injection, tiredness, headache, muscle pain, chills, nausea, feeling unwell, decreased appetite and felt like fainting.  Temp 97.7 at 10:00 am 09/29/21.
pt was vomiting , pt was on the floor, she called the ems twice. second time was taken to the hospital.
Patient came in and requested shingrix shot, went to put in state registration and found that patient received first dose 15 days prior to administration instead of recommended 2-6 month interval
Patient stated she has tingling down arm, sores on back, breaking out in a rash for the 2nd time, numbness up and down spine, extreme fatigue, been in bed and out of work for 6 weeks.
On 29 Oct 2020 around 1030hrs, I had administered the undiluted Pfizer COVID-19 vaccine to patient. At the time of inoculation I was unaware that the Pfizer COVID-19 vaccine had to be reconstituted with 1.8mL Sodium Chloride 0.9%. While retrieving the vaccine I confirmed the name of the vaccine, the expiration date, and the lot number. Once I draw the dose in the syringe, I looked to confirm what I thought was a 0.3ml dose in the syringe and proceeded to vaccinate the patient. Later, on in the duty day it was informed to me that the Pfizer Vaccine is actually a multi-dose vial, not a single dose vial. And that it has to be reconstituted before administering to patients. Upon, being informed this I alerted others about my error and they immediately informed the DO ,who then with the guidance of department and other agencies, contacted the patient to make her aware of the error and given strict follow up instructions and ER precautions.
This case was reported by a consumer via call center representative and described the occurrence of fever in a adult female patient who received SHINGRIX for prophylaxis. Previously administered products included ZOSTAVAX (about 10 years before the date of reporting). On an unknown date, the patient received the 1st dose of SHINGRIX (intramuscular). On an unknown date, several hours after receiving SHINGRIX, the patient experienced fever, chills and fatigue. On an unknown date, the outcome of the fever, chills and fatigue were recovered/resolved. It was unknown if the reporter considered the fever, chills and fatigue to be related to SHINGRIX. Additional details were reported as follows: This case was previously not reported to the physician. The age at vaccination was not reported. The reporter reported that, about 2 and a half months before the date of reporting she received a dose of SHINGRIX (at 10 o clock) in right arm. The reporter stated that, later the evening of her shot, she experienced fever, chills and shivering. She also went to bed because she was so tired. The reporter noted extreme fatigue for 36 hours. The patient also noted fever which recorded as 102 Degree F. The pharmacy where they received the vaccine was onsite at the physician office. This case was linked to case US2018141995, reported by the same reporter.
Patient came to see me yesterday and showed me the 4 inches rash on her left arm. The rash was about 1 inch below the injection site. She said the rash was very bad on Friday after she was immunized got better every day. She took OTC BENADRYL for the rash to be better.
Bell?s palsy onset from 10/31/2011 to 11/14/2011
1hr p/vax dad (an anesthesiologist) noted lower lip quivering, ashen color, blue lips, shaking of extremities (upper) & grunting + salivation, ashen color/whiny on eval;
Rash; Swelling; A spontaneous report was received from a Consumer concerning an unknown age male patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced Swelling, and Rash.     The patient's medical history was not provided. No relevant concomitant medications were reported.    On 07-JAN-2021, prior to the onset of the events, the patient received their first of two planned doses of mRNA-1273 (batch: 011J20A) intramuscularly for prophylaxis of COVID-19 infection. On an unknown date, approximately 10 days after vaccination, the patient experienced Swelling, Rash on the injection arm. The side effects continued to worsen until the patient went to an Emergency Room for detail. The patients doctor informed the patient that he should not receive the second dose of the vaccine.  Treatment for the events included Antibiotics and Prednisone.   The second dose of mRNA-1273 was discontinued in response to the events.   At the time of this report, the outcome of the events, Swelling and Rash were not resolved.; Reporter's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded. Further information has been requested.
Flu like symptoms; low grade fever; Achy; This is a spontaneous report received from a contactable consumer herself (Patient) via a Pfizer Sponsored Program. A female patient of an unspecified age received first doe of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, solution for injection) via an unspecified route of administration on 17Mar2021 (Batch/Lot number: Not provided) as single dose for COVID-19 immunisation. The patient medical history included COVID-19 on 30Jan2021 and concomitant medications were not reported. It was mentioned that patient had her first dose of the vaccine yesterday 17Mar2021. She tested positive for Covid-19 last 30Jan2021. She did a test on 10Feb2021 and results came out negative for Covid. She read from some resources that you should wait 60 to 90 days before taking the vaccine. She was worried if she took the vaccine too soon. She mentioned that she experienced flu like symptoms like low grade fever, achy on an unspecified date in Mar2021. The patient underwent lab tests and procedures which included covid-19: positive on 30Jan2021, covid-19: negative on 10Feb2021. She also mentioned that she took 2 tablets of Tylenol. Outcome of events was unknown.  Follow-up attempts are completed. No further information is expected; information about lot/batch number cannot be obtained.
Nausea ,shortness of breath during the day . Heart stopped 7:45 pm. Death declared at 12:45 am March 09 2021.
presented to ED on 4/4 with slurred speech and numbness since this am, but more than 24 hrs; diagnosed with CVA, ischemic stroke.   dizziness past 1-2 weeks
vision loss; Information has been received from a lawyer regarding a case in litigation referring to a female patient of unknown age. Information about medical history, concurrent condition and concomitant medication was not reported. In or around March 2018, the patient was vaccinated with zoster vaccine live (ZOSTAVAX) (strength, dose, route, lot# and expiration date not reported) for routine health maintenance and for its intended purpose: the prevention of shingles (herpes zoster). On an unknown date (reported as shortly after receiving zoster vaccine live (ZOSTAVAX)), the patient suffered vision loss. As a direct and proximate result of zoster vaccine live (ZOSTAVAX), the patient's symptoms have resulted in physical limitations not present prior to using zoster vaccine live (ZOSTAVAX). The patient also experienced mental and emotional distress due to resulting physical limitations and seriousness of patient's condition. As a result of the manufacture, marketing, advertising, promotion, distribution and/or sale of zoster vaccine live (ZOSTAVAX), the patient sustained severe and permanent personal injuries. Further, as a tragic consequence of zoster vaccine live (ZOSTAVAX), the patient suffered serious, progressive, permanent, and incurable injuries, as well as significant conscious pain and suffering, mental anguish, emotional distress, loss of enjoyment of life, physical impairment and injury. As a direct and proximate result of zoster vaccine live (ZOSTAVAX), the patient had suffered and incurred damages, including medical expenses; the loss of accumulations; and other economic and non-economic damages. The outcome of the event vision loss was not recovered. The lawyer considered vision loss to be related to zoster vaccine live (ZOSTAVAX).   The event vision loss was considered by the lawyer as disability.  Upon internal review, the event vision loss was determined to be medically significant event.
She got her vaccine, she was fine, drove herself home 5-10 minutes, felt fine until her arm started to feel hot and a rash broke out.  There was lump at the injection site.  Then she felt like she had a lightening strike through her body, and felt like she had the flu the next day.  She could not move and it lasted only a day and she stayed in the bed, and it went away.  She had a low grade temp of 100, normal temp 97.  She then woke up on Wednesday with a rash at the injection site to the elbow but used hydrocortisone cream which did not release the pain and used a cold compress to remove the heat from her arm.  The cortisone cream did not work and she called the doctor who prescribed Benadryl cream and Benadryl to take (allergic to).  Cream worked, Benadryl made her sick so now lists that as an allergy.  She then took Claritin and it worked, but the rash remained.  She got a rash then on the back of her right thigh, and she had hives on both knees (one on each knee and on the elbows).  The rash on her arm was there and had to use cold compresses and eventually by Friday of that week it subsided .  Annoying due to the itching, but not painful.  The rash on the thigh went away the next day.  Also had rash on her buttocks, which went away the next day as well.   Has been fine since the Friday after the vaccine.    She saw her doctor who told her to take the shot, her son is a Dr. and they told her to take it.   All of her family members and friends had no reactions.
100.8 Fahrenheit fever, chills, palpitations, bones aching in a throbbing manner, fatigue, brain fog
A little arm soreness; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (A little arm soreness) in an 89-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 002A21A) for COVID-19 vaccination.     Concurrent medical conditions included Depression. Concomitant products included SERTRALINE HYDROCHLORIDE (ZOLOFT) and MENTHOL (BIOFREEZE PAIN RELIEVING) for an unknown indication.   On 25-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (A little arm soreness). At the time of the report, PAIN IN EXTREMITY (A little arm soreness) outcome was unknown.            Concomitants were provided blood pressure medication. thyroid medication and cholesterol medication.   Reporter did not allow further contact
Headache and arm hurt in PM on day of shot 1/21/2021 Headache, muscle and joint pain, fatigue on 1/22/2021
Blotchy red rash that itches and feels warm to the touch developed an inch or so below the injection site that covers much of my upper arm.  This first appeared on day 4 after the shot.  I plan to take an anti-histamine to treat the reaction.  I also experienced a slight fever, chills, body aches, and stomach pains lasting about 5-6 hours, starting about 18 hours after my shot.   After that, I had a slight intermittent headache on days 2, 3, and 4 after the shot.
Weakness in legs that progressed from feet to thighs and caused her to fall. Admitted to hosp with Guillain-Barre syndrome.
Called 7/15/11 and 7/22/11 experiencing, (L) neck and shoulder pain since Td given 7/8/11 - seen at urgent care 7/15/11 given pain medicine -no change in pain as of 7/22/11.
Rashes appeared on elbows, inside of wrist, injection site and thigh area. Took Benadryl.
Pt recvd 3 doses of Engerix-B 10NOV89, 10DEC89, & 10JUN90 & reporter indicated that pt exp a lack of therapeutic effect;
First dose > 35 days ago; This spontaneous case was reported by a pharmacist and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (First dose > 35 days ago) in a 33-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    In March 2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PRODUCT DOSE OMISSION ISSUE (First dose > 35 days ago). At the time of the report, PRODUCT DOSE OMISSION ISSUE (First dose > 35 days ago) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medication provided.  No treatment information mentioned.
About a week  after the second shot I experienced some minor chest pain that would go away some  if I stretched and some heart palpitations that I had never experienced before - for about 3 weeks.   The heart palpitations were frightening to me.      Reaction to second Moderna shot was quite intense for 2-3 days with chills and fever near 101F - have not had a fever that high in 30 years since I was a kid/teenager (for me it was a high fever).    Was wearing a winter jacket while working and it was 70F.      EKG was normal when I could get one (mid June) and the conditions seems to have have mostly cleared.     Quite strange how it aligned a week after the shot and the fever.   I felt this should be made available for metadata review, esp after later hearing of reports in younger males of heart issues the past month.     I have routinely gotten flu shots/etc and never had any kind of reaction like this.
Stroke on 2/12/2021, death on 2/28/2021 Was in 3 hospitals:
SORENESS IN ELBOW, WRIST AND KNUCKLES; SORENESS IN ARM, HAND AND FINGERS; INJECTION SITE SORENESS; DIFFICULTY USING HAND; SWOLLEN SHOULDER; INJECTION SITE BRUISING; This spontaneous report received from a patient concerned a 71 year old female. The patient's weight, height, and medical history were not reported. The patient received Tylenol unspecified (form of admin, route of admin, and batch number were not reported) dose, frequency, and therapy dates were not reported for an unspecified indication. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1808980, expiry: 20-JUN-2021) dose was not reported, administered on 31-MAR-2021 on left arm for prophylactic vaccination. No concomitant medications were reported. On 2021, the patient experienced injection site bruising. On 02-APR-2021, the patient experienced difficulty using hand. On 02-APR-2021, the patient experienced swollen shoulder. On 02-APR-2021, the patient experienced injection site soreness. On 03-APR-2021, the patient experienced soreness in arm, hand and fingers. On 04-APR-2021, the patient experienced soreness in elbow, wrist and knuckles. The action taken with covid-19 vaccine ad26.cov2.s was not applicable; and action taken with Tylenol unspecified was not reported. The patient had not recovered from injection site soreness, difficulty using hand, swollen shoulder, injection site bruising, soreness in elbow, wrist and knuckles, and soreness in arm, hand and fingers. This report was non-serious.
Onset acute blood loss due to internal bleeding on approximately 05/09/21, upper GI bleeding and anemia. Hemoglobin dropped to 5.2 resulting in death. Hospitalization on 05/12/21 discharged to Hospice Care 05/15/21 loss of life on 05/22/21.
Per telephone discussion MD on Tue 13AUG91 pt was brought to Hosp; ER by ambulance approx 430PM; family thinks he had convuls; MD disagrees & feels there was no relation to immun given 9AUG91; all studies were normal; pt was conscious;
AFTER MY FIRST DOSE OF THE PFIZER COVID-19 VACCINE,MY LEFT ARM HURTED FOR A LIL BIT THE NEXT DAY AROUND THE MORING TIME.BUT AROUND 12PM AFTERNOON 4/30/2021 MY LEFT SIDE OF MY FACE STARTED TO GET A NUMB FEELING.IT HAS BEEN FEELING LIKE THIS ALMOST A FULL MONTH NOW,AFTER TAKING MY SECOND DOSE OF THE PFIZER COVID-19 VACCINE,NOTHING HAS CHANGED.IT STILL FEELS THE SAME,I HAVE TO KEEP RUBING MY FACE BECAUSE IF I DONT IT WILL START TO GET NUMB EVERY TIME.I DONT LIKE THIS FEELING AT ALL,I GOT THE SHOTS BECAUSE I WANTED TO FEEL SAFE,AND MAKE SURE THE PEOPLE AROUND ME WAS ALSO SAFE.SO I NEED HELP NOW,I NEED SOMETHING TO HELP ME BEFORE IT GETS WORSE.